Introducing SiMCare Diabetes - the first in a series of chronic disease management learning programs employing simulations based on actual patient cases.
Developed for Primary Care providers, SiMCare Diabetes employs simulations of actual patient/physician interactions to help healthcare providers diagnose and treat type 1 & 2 diabetes more effectively. Learners will actively manage the disease states of ‘virtual’ patients and engage in realistic treatment based on current best practices:
- Manage insulin use
- Prescribe medications
- Order diagnostic tests and lab work
- Initiate interventional therapies
- Refer the patient to specialists
- Provide patient advice
As the care provider, the learner decides when and how often to bring the patient to the clinic to ensure proper control of the disease. Each case challenges the learner to help the patient achieve a specific goal within 6 months (20-30 minutes in real time).
The simulation engine has a sophisticated and validated patient model with simulated states that change over time as diabetes progresses or responds to the primary caregiver’s interventional strategy. The entire curriculum, containing 18 diverse case scenarios, is compatible with PC, Mac and iPad, and can be completed within several hours at the learner’s convenience.
Patient/Physician scenarios are based on thousands of actual patient/physician encounters based on data collected over several years and sponsored by the National Institutes of Health (NIH) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
SiMCare was developed by HealthPartners in collaboration with the University of Minnesota.
Study results of the efficacy of SiMCare Diabetes:
Physician residents on simulated patients:
- 5x higher ability to achieve clinical care goals
- 3x higher on diabetes knowledge testing
- 60% reduction in contraindicated medication prescribing
- 92% reported more confidence in the use of insulin
Practicing physicians on real patients:
- Significantly improved glycemic control in patients with A1C > 7.0%
- Costs per patient reduced by an average of $71/patient
- Substantial reduction in risky prescribing of medications
Publications around SiMCare Diabetes: